Bristol Myers Squibb Net Income 2006-2021 | BMY

Bristol Myers Squibb annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Bristol Myers Squibb net income for the quarter ending September 30, 2021 was $1.546B, a 17.41% decline year-over-year.
  • Bristol Myers Squibb net income for the twelve months ending September 30, 2021 was $-5.405B, a 12184.09% increase year-over-year.
  • Bristol Myers Squibb annual net income for 2020 was $-9.015B, a 362.14% decline from 2019.
  • Bristol Myers Squibb annual net income for 2019 was $3.439B, a 30.1% decline from 2018.
  • Bristol Myers Squibb annual net income for 2018 was $4.92B, a 388.58% increase from 2017.
Bristol Myers Squibb Annual Net Income
(Millions of US $)
2020 $-9,015
2019 $3,439
2018 $4,920
2017 $1,007
2016 $4,457
2015 $1,565
2014 $2,004
2013 $2,563
2012 $1,959
2011 $3,701
2010 $3,090
2009 $10,594
2008 $5,247
2007 $2,165
2006 $1,585
2005 $3,000
Bristol Myers Squibb Quarterly Net Income
(Millions of US $)
2021-09-30 $1,546
2021-06-30 $1,055
2021-03-31 $2,021
2020-12-31 $-10,027
2020-09-30 $1,872
2020-06-30 $-85
2020-03-31 $-775
2019-12-31 $-1,056
2019-09-30 $1,353
2019-06-30 $1,432
2019-03-31 $1,710
2018-12-31 $1,160
2018-09-30 $1,901
2018-06-30 $373
2018-03-31 $1,486
2017-12-31 $-2,328
2017-09-30 $845
2017-06-30 $916
2017-03-31 $1,574
2016-12-31 $894
2016-09-30 $1,202
2016-06-30 $1,166
2016-03-31 $1,195
2015-12-31 $-197
2015-09-30 $706
2015-06-30 $-130
2015-03-31 $1,186
2014-12-31 $13
2014-09-30 $721
2014-06-30 $333
2014-03-31 $937
2013-12-31 $726
2013-09-30 $692
2013-06-30 $536
2013-03-31 $609
2012-12-31 $924
2012-09-30 $-711
2012-06-30 $645
2012-03-31 $1,101
2011-12-31 $850
2011-09-30 $967
2011-06-30 $900
2011-03-31 $984
2010-12-31 $471
2010-09-30 $949
2010-06-30 $927
2010-03-31 $743
2009-12-31 $8,007
2009-09-30 $966
2009-06-30 $983
2009-03-31 $638
2008-12-31 $1,244
2008-09-30 $2,578
2008-06-30 $764
2008-03-31 $661
2007-12-31 $-89
2007-09-30 $858
2007-06-30 $706
2007-03-31 $690
2006-12-31 $-134
2006-09-30 $338
2006-06-30 $667
2006-03-31 $714
2005-12-31 $499
2005-09-30 $964
2005-06-30 $1,004
2005-03-31 $533
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $121.281B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.681B 21.48
Biohaven Pharmaceutical Holding (BHVN) United States $7.357B 0.00
Arcus Biosciences (RCUS) United States $3.170B 0.00
Emergent Biosolutions (EBS) United States $2.265B 8.14
Myovant Sciences (MYOV) United Kingdom $1.741B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.500B 0.00
Zymeworks (ZYME) Canada $0.902B 0.00
Ambrx Biopharma (AMAM) United States $0.391B 0.00
SQZ Biotechnologies (SQZ) United States $0.337B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.95